TriangleFOR PATIENTS · SOURCE READING
Targeted therapy
Source: Childhood Multiple Endocrine Neoplasia Type 2 (MEN2) Syndrome, National Cancer Institute.
Source updated: Not stated in this source · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
NCI patient article for the named subtype within this topic Source-defined subtype article; do not apply its treatment text to every subtype in the umbrella topic.
Context: Types of treatment for children with tumors caused by MEN2 syndrome
Targeted therapy uses drugs or other substances to block the action of specific enzymes, proteins, or other molecules involved in the growth of tumor cells.
Source links and citations
Selpercatinib and vandetanib are used to treat medullary thyroid cancer caused by MEN2 syndrome.
Source links and citations
Learn more about Targeted Therapy to Treat Cancer.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice